Cabergoline as treatment of ovarian hyperstimulation syndrome: a review.
about
Cabergoline, dopamine D2 receptor agonist, prevents neuronal cell death under oxidative stress via reducing excitotoxicityPredictive factors for recovery time in patients suffering from severe OHSS.Dopamine agonists for preventing ovarian hyperstimulation syndrome.Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.Management of ovarian hyperstimulation syndrome with abdominal compartment syndrome, based on intravesical pressure measurement.
P2860
Cabergoline as treatment of ovarian hyperstimulation syndrome: a review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cabergoline as treatment of ovarian hyperstimulation syndrome: a review.
@en
type
label
Cabergoline as treatment of ovarian hyperstimulation syndrome: a review.
@en
prefLabel
Cabergoline as treatment of ovarian hyperstimulation syndrome: a review.
@en
P2093
P2860
P1476
Cabergoline as treatment of ovarian hyperstimulation syndrome: a review.
@en
P2093
Emmanouil Kalampokas
George Creatsas
Theodoros Kalampokas
P2860
P304
P356
10.3109/09513590.2012.730578
P577
2012-10-30T00:00:00Z